Giving probiotics to premature babies on a daily basis may help prevent a severe intestinal disease, according to reporting from News-Medical published on 30 September 2026.
The condition in question is necrotizing enterocolitis, a serious gut disease that affects preterm infants. News-Medical reports that regular probiotic supplementation is linked to a reduced risk of the illness.
The finding adds to a body of coverage pointing in the same direction. CIDRAP has also reported on a separate study that connects a multistrain probiotic to a lower risk of necrotizing enterocolitis in preterm infants.
Both reports focus on the same underlying question: whether routine probiotic use can protect premature babies from a disease that remains a significant concern in neonatal care. The two outlets describe the approach as preventive, with the probiotics given as a daily regimen rather than as a treatment after symptoms appear.
The available material does not specify dosages, which bacterial strains were used, how many infants were studied, or where the research was carried out. It also does not state whether the findings come from a randomized trial, an observational study, or a review of existing data. Readers should treat the results as reported by News-Medical and CIDRAP rather than as established clinical guidance.
What to watch next: whether full study details, including strain selection and patient outcomes, are released, and whether clinical bodies update their recommendations for probiotic use in preterm infants.
